home · filing · 0001493152-26-027500
8-K
filed June 5, 2026, 4:30 PM ET
ticker JUNS
CIK 0001679628
leadership
confidence high
sentiment neutral
materiality 0.50
Jupiter Neurosciences names Silva COO/President; awards options to execs and directors
JUPITER NEUROSCIENCES, INC.
Alison Silva appointed COO and President; base salary raised to $340,200 from $315,000.
Silva granted 600,000 stock options vesting quarterly over three years starting Sept 2, 2026.
Independent non-employee directors each granted 100,000 options on same vesting schedule.
Discretionary bonus options awarded: C. Rosén (747,783), Silva (427,304), Elmasri (325,565), Hayward (259,231), A. Rosén (341,843).
CFO Saleem Elmasri received an additional one-time grant of 200,000 options.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2026-06-05
Filed June 5, 2026, 4:30 PM ET
The Amendment appoints Ms. Silva as the Company’s Chief Operating Officer and President
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alison Silva was appointed as Chief Operating Officer and President at JUPITER NEUROSCIENCES, INC..
Action appointed
Role Chief Operating Officer and President
Exact text from the filing
The Amendment appoints Ms. Silva as the Company’s Chief Operating Officer and President
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-26-027500
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.